30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Longeveron Inc (LGVN)

Track

The most recent insider trading activity occurred on May 30, 2025, with multiple SELL transactions by Soffer Rock. Prior to this, significant BUY transactions were noted in April 2024 by key executives including the CEO and CSO. The pattern shows a shift from buying to selling in recent months.
Stock chart
Ticker: LGVN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Soffer Rock
1 sale — total 13,750 USD
Sale 30 May 2025
Value US$4,020,803.21 | Price 170.49 | Shares 75,838
Sale 29 May 2025
Value US$723,908.22 | Price 25.91 | Shares 36,369
Proposed sale 29 May 2025
Value US$26,775.00 | Price 1.28 | Shares 21,000
Sale 22 May 2025
Value US$2,640.00 | Price 1.32 | Shares 2,000
Sale 16 May 2025
Value US$7,367.32 | Price 1.40 | Shares 5,250
Proposed sale 15 May 2025
Value US$7,220.00 | Price 1.38 | Shares 5,250
Sale 2 Dec 2024
Value US$2,588.12 | Price 2.07 | Shares 1,250
Proposed sale 27 Nov 2024
Value US$2,575.00 | Price 2.06 | Shares 1,250
Buy 11 Apr 2024
Value US$99,999.55 | Price 2.35 | Shares 42,553
Buy 11 Apr 2024
Value US$24,999.30 | Price 2.35 | Shares 10,638
Buy 11 Apr 2024
Value US$75,000.25 | Price 2.35 | Shares 31,915
Buy 10 Apr 2024
Value US$250,000.05 | Price 2.35 | Shares 106,383
Buy 10 Apr 2024
Value US$250,000.05 | Price 2.35 | Shares 106,383
Buy 10 Jan 2024
Value US$6,544.50 | Price 1.31 | Shares 5,000
Buy 29 Dec 2023
Value US$11,914.61 | Price 1.43 | Shares 8,322
Buy 28 Dec 2023
Value US$2,341.98 | Price 1.40 | Shares 1,678
Buy 28 Dec 2023
Value US$13,500.00 | Price 1.35 | Shares 10,000
Sale 29 Jun 2023
Value US$17,550.00 | Price 3.51 | Shares 5,000
Sale 28 Jun 2023
Value US$34,300.00 | Price 3.43 | Shares 10,000
Sale 27 Jun 2023
Value US$29,691.36 | Price 3.48 | Shares 8,532
Planned sale 27 Jan 2023
Value US$85,600.00 | Price 4.28 | Shares 20,000
Planned sale 2 Dec 2022
Value US$74,800.00 | Price 3.74 | Shares 20,000
Sale 12 Oct 2022
Value US$361,000.00 | Price 3.61 | Shares 100,000
Sale 3 Jun 2022
Value US$305,248.30 | Price 8.26 | Shares 36,955
Sale 24 May 2022
Value US$30,000.00 | Price 7.50 | Shares 4,000
Sale 23 May 2022
Value US$62,200.00 | Price 7.78 | Shares 8,000
Sale 20 May 2022
Value US$60,435.00 | Price 8.06 | Shares 7,500
Planned sale 19 Apr 2022
Value US$780.00 | Price 10.00 | Shares 78
Planned sale 18 Apr 2022
Value US$199,289.73 | Price 10.00 | Shares 19,922
Buy 13 Oct 2021
Value US$3,810.00 | Price 3.81 | Shares 1,000
Buy 13 Oct 2021
Value US$45,120.00 | Price 3.76 | Shares 12,000
Buy 12 Oct 2021
Value US$9,225.00 | Price 3.69 | Shares 2,500
Buy 12 Oct 2021
Value US$14,280.00 | Price 3.57 | Shares 4,000
Buy 11 Oct 2021
Value US$13,455.00 | Price 3.45 | Shares 3,900
Buy 8 Oct 2021
Value US$10,220.85 | Price 3.39 | Shares 3,015
Buy 7 Oct 2021
Value US$6,709.30 | Price 3.38 | Shares 1,985
Buy 7 Oct 2021
Value US$5,845.00 | Price 3.34 | Shares 1,750
Buy 7 Oct 2021
Value US$16,700.00 | Price 3.34 | Shares 5,000
Buy 12 Feb 2021
Value US$1,000,000.00 | Price 10.00 | Shares 100,000
Buy 12 Feb 2021
Value US$805.00 | Price 8.05 | Shares 100
Buy 12 Feb 2021
Value US$8,230.00 | Price 8.23 | Shares 1,000
Buy 12 Feb 2021
Value US$1,020,000.00 | Price 10.00 | Shares 102,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-02 2025-05-30 S Sale
3.2
Soffer Rock
Non-Executive Director
75,838 -4.8%
170.49
US$4,020,803 		75,838 -4.8% 170.49 US$4,020,803
2025-06-02 2025-05-29 S Sale
3.2
Soffer Rock
Non-Executive Director
36,369 +19.3%
25.91
US$723,908 		36,369 +19.3% 25.91 US$723,908
2025-05-29 2025-05-29 PrS Proposed sale
3.2
Rock Soffer

Director

Non-Executive Director
749
125.91
US$3,788,865 		749 125.91 US$3,788,865
2025-05-27 2025-05-22 S Sale
3.2
Soffer Rock
Non-Executive Director
2,000 -0.9%
1.32
US$2,640 		2,000 -0.9% 1.32 US$2,640
2025-05-16 2025-05-16 S Sale
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
5,250 -0.7%
1.40
US$7,367 		5,250 -0.7% 1.40 US$7,367
2025-05-15 2025-05-15 PrS Proposed sale
1.7
Hare Joshua

Officer; Director

Executive Director
5,250
1.38
US$7,220 		5,250 1.38 US$7,220
2024-12-04 2024-12-02 S Sale
2.3
Baluch Khoso
Non-Executive Director
1,250 -5.0%
2.07
US$2,588 		1,250 -5.0% 2.07 US$2,588
2024-11-27 2024-11-27 PrS Proposed sale
2.3
Baluch Khoso

Director

Non-Executive Director
1,250
2.06
US$2,575 		1,250 2.06 US$2,575
2024-04-12 2024-04-11 B Purchase
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
42,553 +7.2%
2.35
US$100,000 		42,553 +7.2% 2.35 US$100,000
2024-04-12 2024-04-11 B Purchase
2.2
Hashad Mohamed Wa'el Ahmed

Chief Executive Officer

Executive Director
10,638 +118.5%
2.35
US$24,999 		10,638 +118.5% 2.35 US$24,999
2024-04-12 2024-04-11 B Purchase
3.2
Soffer Rock
Non-Executive Director
31,915 +18.1%
2.35
US$75,000 		31,915 +18.1% 2.35 US$75,000
2024-04-12 2024-04-10 B Purchase
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
106,383 +22.0%
2.35
US$250,000 		106,383 +22.0% 2.35 US$250,000
2024-04-12 2024-04-10 B Purchase
3.2
Soffer Rock
Non-Executive Director
106,383 +151.5%
2.35
US$250,000 		106,383 +151.5% 2.35 US$250,000
2024-01-11 2024-01-10 B Purchase
0.5
Ross Cathy
Non-Executive Director
5,000 +100.0%
1.31
US$6,544 		5,000 +100.0% 1.31 US$6,544
2024-01-02 2023-12-29 B Purchase
2.3
Baluch Khoso
Non-Executive Director
8,322 +124.6%
1.43
US$11,915 		8,322 +124.6% 1.43 US$11,915
2024-01-02 2023-12-28 B Purchase
2.3
Baluch Khoso
Non-Executive Director
1,678 +33.6%
1.40
US$2,342 		1,678 +33.6% 1.40 US$2,342
2023-12-29 2023-12-28 B Purchase
0.5
PFEFFER JEFFREY
Non-Executive Director
10,000 +200.0%
1.35
US$13,500 		10,000 +200.0% 1.35 US$13,500
2023-06-29 2023-06-29 S Sale
3.6
Clavijo James

CFO and Treasurer

Officer
5,000 -9.6%
3.51
US$17,550 		5,000 -9.6% 3.51 US$17,550
2023-06-29 2023-06-28 S Sale
3.6
Clavijo James

CFO and Treasurer

Officer
10,000 -16.1%
3.43
US$34,300 		10,000 -16.1% 3.43 US$34,300
2023-06-29 2023-06-27 S Sale
3.6
Clavijo James

CFO and Treasurer

Officer
8,532 -12.0%
3.48
US$29,691 		8,532 -12.0% 3.48 US$29,691
2023-01-30 2023-01-27 PlS Planned sale
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
20,000 -0.3%
4.28
US$85,600 		20,000 -0.3% 4.28 US$85,600
2022-12-05 2022-12-02 PlS Planned sale
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
20,000 -0.3%
3.74
US$74,800 		20,000 -0.3% 3.74 US$74,800
2022-10-18 2022-10-12 S Sale
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
100,000 -1.3%
3.61
US$361,000 		100,000 -1.3% 3.61 US$361,000
2022-06-07 2022-06-03 S Sale
3.6
Clavijo James

CFO and Treasurer

Officer
36,955 -31.7%
8.26
US$305,248 		36,955 -31.7% 8.26 US$305,248
2022-05-24 2022-05-24 S Sale
3.2
Soffer Rock
Non-Executive Director
4,000 -0.6%
7.50
US$30,000 		4,000 -0.6% 7.50 US$30,000
2022-05-24 2022-05-23 S Sale
3.2
Soffer Rock
Non-Executive Director
8,000 -1.2%
7.78
US$62,200 		8,000 -1.2% 7.78 US$62,200
2022-05-24 2022-05-20 S Sale
3.2
Soffer Rock
Non-Executive Director
7,500 -1.1%
8.06
US$60,435 		7,500 -1.1% 8.06 US$60,435
2022-04-20 2022-04-19 PlS Planned sale
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
78 -0.0%
10.00
US$780 		78 -0.0% 10.00 US$780
2022-04-20 2022-04-18 PlS Planned sale
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
19,922 -0.3%
10.00
US$199,290 		19,922 -0.3% 10.00 US$199,290
2021-10-14 2021-10-13 B Purchase
2.5
Green Geoff

CEO

Officer
1,000 +0.7%
3.81
US$3,810 		1,000 +0.7% 3.81 US$3,810
2021-10-13 2021-10-13 B Purchase
3.2
Soffer Rock
Non-Executive Director
12,000 +30.2%
3.76
US$45,120 		12,000 +30.2% 3.76 US$45,120
2021-10-14 2021-10-12 B Purchase
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
2,500 +0.0%
3.69
US$9,225 		2,500 +0.0% 3.69 US$9,225
2021-10-13 2021-10-12 B Purchase
3.2
Soffer Rock
Non-Executive Director
4,000 +11.2%
3.57
US$14,280 		4,000 +11.2% 3.57 US$14,280
2021-10-13 2021-10-11 B Purchase
3.2
Soffer Rock
Non-Executive Director
3,900 +12.2%
3.45
US$13,455 		3,900 +12.2% 3.45 US$13,455
2021-10-12 2021-10-08 B Purchase
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
3,015 +0.0%
3.39
US$10,221 		3,015 +0.0% 3.39 US$10,221
2021-10-12 2021-10-07 B Purchase
1.7
Hare Joshua

Chief Scientific Officer

Executive Director Large shareholder
1,985 +0.0%
3.38
US$6,709 		1,985 +0.0% 3.38 US$6,709
2021-10-12 2021-10-07 B Purchase
3.3
Lehr Paul T

General Counsel, Secretary

Officer
1,750 +1.5%
3.34
US$5,845 		1,750 +1.5% 3.34 US$5,845
2021-10-12 2021-10-07 B Purchase
3.6
Clavijo James

CFO and Treasurer

Officer
5,000 +6.7%
3.34
US$16,700 		5,000 +6.7% 3.34 US$16,700
2021-02-26 2021-02-12 B Purchase
0.5
Soffer Donald M
Non-Executive Director
100,000 +186.9%
10.00
US$1,000,000 		100,000 +186.9% 10.00 US$1,000,000
2021-02-26 2021-02-12 B Purchase
3.2
Soffer Rock
Non-Executive Director
100 +0.4%
8.05
US$805 		100 +0.4% 8.05 US$805
2021-02-17 2021-02-12 B Purchase
1.7
Hare Joshua

Chief Scientific Officer

Executive Director
1,000 +0.0%
8.23
US$8,230 		1,000 +0.0% 8.23 US$8,230
2021-02-17 2021-02-12 B Purchase
1.7
Hare Joshua

Chief Scientific Officer

Executive Director
102,000 +1.3%
10.00
US$1,020,000 		102,000 +1.3% 10.00 US$1,020,000
Explore more

More insider trading research around Longeveron Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America